NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Sell
32
RHE Quote, Financials, Valuation and Earnings
Last price:
$1.47
Seasonality move
:
19.6%
Day range:
$1.49 - $1.51
52-week range:
$1.13 - $3.08
Dividend yield:
0%
P/E ratio:
0.13x
P/S ratio:
0.16x
P/B ratio:
--
Volume:
7.6K
Avg. volume:
27.5K
1-year change:
-24.5%
Market cap:
$2.8M
Revenue:
$17.2M
EPS (TTM):
-$1.55
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
RHE
Regional Health Properties
|
-- | -- | -- | -- | -- |
|
ADUS
Addus HomeCare
|
$289.5M | $1.28 | 1.35% | 12.56% | $137.82 |
|
AMED
Amedisys
|
$588.8M | $1.17 | 4.55% | 80.17% | -- |
|
HCAT
Health Catalyst
|
$76.4M | $0.09 | 7.55% | -- | -- |
|
OPCH
Option Care Health
|
$1.2B | $0.32 | 12.91% | 6.29% | -- |
|
OPRX
OptimizeRx
|
$25M | $0.06 | 4.13% | -69.17% | $10.36 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
RHE
Regional Health Properties
|
$1.51 | -- | $2.8M | 0.13x | $0.00 | 0% | 0.16x |
|
ADUS
Addus HomeCare
|
$131.40 | $137.82 | $2.4B | 30.07x | $0.00 | 0% | 1.95x |
|
AMED
Amedisys
|
$84.49 | -- | $2.8B | 33.53x | $0.00 | 0% | 1.20x |
|
HCAT
Health Catalyst
|
$7.10 | -- | $432M | -- | $0.00 | 0% | 1.39x |
|
OPCH
Option Care Health
|
$22.91 | -- | $3.9B | 19.25x | $0.00 | 0% | 0.84x |
|
OPRX
OptimizeRx
|
$4.89 | $10.36 | $90.1M | -- | $0.00 | 0% | 1.01x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
RHE
Regional Health Properties
|
105.42% | -0.982 | 206.21% | 0.51x |
|
ADUS
Addus HomeCare
|
-- | 1.713 | -- | 2.03x |
|
AMED
Amedisys
|
24.97% | -0.159 | 11.88% | 1.12x |
|
HCAT
Health Catalyst
|
49.29% | 1.912 | 69.66% | 1.36x |
|
OPCH
Option Care Health
|
43.8% | 2.260 | 20.87% | 1.19x |
|
OPRX
OptimizeRx
|
23.56% | 4.188 | 24.93% | 2.93x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
RHE
Regional Health Properties
|
$1.9M | -$300K | -5.98% | -489.72% | -7.22% | -$147K |
|
ADUS
Addus HomeCare
|
$92.2M | $26M | 8.42% | 9.24% | 9.61% | $46.6M |
|
AMED
Amedisys
|
$250.1M | $47M | 5.39% | 7.23% | 6.26% | $104M |
|
HCAT
Health Catalyst
|
$34M | -$13.7M | -12.86% | -21.76% | -11.89% | $1.8M |
|
OPCH
Option Care Health
|
$256.7M | $85.1M | 8.33% | 14.65% | 6.72% | $150.7M |
|
OPRX
OptimizeRx
|
$13.4M | -$1.1M | -16.25% | -20.12% | -39.5% | $1.7M |
Regional Health Properties vs. Competitors
-
Which has Higher Returns RHE or ADUS?
Addus HomeCare has a net margin of -23.24% compared to Regional Health Properties's net margin of 6.96%. Regional Health Properties's return on equity of -489.72% beat Addus HomeCare's return on equity of 9.24%.
Company Gross Margin Earnings Per Share Invested Capital RHERegional Health Properties44.9% -$0.52 $43.9M ADUSAddus HomeCare31.82% $1.10 $947.6M -
What do Analysts Say About RHE or ADUS?
Regional Health Properties has a consensus price target of --, signalling upside risk potential of 330.46%. On the other hand Addus HomeCare has an analysts' consensus of $137.82 which suggests that it could grow by 4.89%. Given that Regional Health Properties has higher upside potential than Addus HomeCare, analysts believe Regional Health Properties is more attractive than Addus HomeCare.
Company Buy Ratings Hold Ratings Sell Ratings RHERegional Health Properties0 0 0 ADUSAddus HomeCare8 0 0 -
Is RHE or ADUS More Risky?
Regional Health Properties has a beta of 0.916, which suggesting that the stock is 8.446% less volatile than S&P 500. In comparison Addus HomeCare has a beta of 1.015, suggesting its more volatile than the S&P 500 by 1.53%.
-
Which is a Better Dividend Stock RHE or ADUS?
Regional Health Properties has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Addus HomeCare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Regional Health Properties pays -- of its earnings as a dividend. Addus HomeCare pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RHE or ADUS?
Regional Health Properties quarterly revenues are $4.2M, which are smaller than Addus HomeCare quarterly revenues of $289.8M. Regional Health Properties's net income of -$982K is lower than Addus HomeCare's net income of $20.2M. Notably, Regional Health Properties's price-to-earnings ratio is 0.13x while Addus HomeCare's PE ratio is 30.07x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Regional Health Properties is 0.16x versus 1.95x for Addus HomeCare. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RHERegional Health Properties0.16x 0.13x $4.2M -$982K ADUSAddus HomeCare1.95x 30.07x $289.8M $20.2M
-
Which has Higher Returns RHE or AMED?
Amedisys has a net margin of -23.24% compared to Regional Health Properties's net margin of 2.88%. Regional Health Properties's return on equity of -489.72% beat Amedisys's return on equity of 7.23%.
Company Gross Margin Earnings Per Share Invested Capital RHERegional Health Properties44.9% -$0.52 $43.9M AMEDAmedisys42.56% $0.51 $1.6B -
What do Analysts Say About RHE or AMED?
Regional Health Properties has a consensus price target of --, signalling upside risk potential of 330.46%. On the other hand Amedisys has an analysts' consensus of -- which suggests that it could grow by 14.02%. Given that Regional Health Properties has higher upside potential than Amedisys, analysts believe Regional Health Properties is more attractive than Amedisys.
Company Buy Ratings Hold Ratings Sell Ratings RHERegional Health Properties0 0 0 AMEDAmedisys0 0 0 -
Is RHE or AMED More Risky?
Regional Health Properties has a beta of 0.916, which suggesting that the stock is 8.446% less volatile than S&P 500. In comparison Amedisys has a beta of 0.726, suggesting its less volatile than the S&P 500 by 27.385%.
-
Which is a Better Dividend Stock RHE or AMED?
Regional Health Properties has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Amedisys offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Regional Health Properties pays -- of its earnings as a dividend. Amedisys pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RHE or AMED?
Regional Health Properties quarterly revenues are $4.2M, which are smaller than Amedisys quarterly revenues of $587.7M. Regional Health Properties's net income of -$982K is lower than Amedisys's net income of $16.9M. Notably, Regional Health Properties's price-to-earnings ratio is 0.13x while Amedisys's PE ratio is 33.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Regional Health Properties is 0.16x versus 1.20x for Amedisys. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RHERegional Health Properties0.16x 0.13x $4.2M -$982K AMEDAmedisys1.20x 33.53x $587.7M $16.9M
-
Which has Higher Returns RHE or HCAT?
Health Catalyst has a net margin of -23.24% compared to Regional Health Properties's net margin of -19.29%. Regional Health Properties's return on equity of -489.72% beat Health Catalyst's return on equity of -21.76%.
Company Gross Margin Earnings Per Share Invested Capital RHERegional Health Properties44.9% -$0.52 $43.9M HCATHealth Catalyst44.58% -$0.24 $700.1M -
What do Analysts Say About RHE or HCAT?
Regional Health Properties has a consensus price target of --, signalling upside risk potential of 330.46%. On the other hand Health Catalyst has an analysts' consensus of -- which suggests that it could grow by 60.69%. Given that Regional Health Properties has higher upside potential than Health Catalyst, analysts believe Regional Health Properties is more attractive than Health Catalyst.
Company Buy Ratings Hold Ratings Sell Ratings RHERegional Health Properties0 0 0 HCATHealth Catalyst0 0 0 -
Is RHE or HCAT More Risky?
Regional Health Properties has a beta of 0.916, which suggesting that the stock is 8.446% less volatile than S&P 500. In comparison Health Catalyst has a beta of 1.315, suggesting its more volatile than the S&P 500 by 31.457%.
-
Which is a Better Dividend Stock RHE or HCAT?
Regional Health Properties has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Health Catalyst offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Regional Health Properties pays -- of its earnings as a dividend. Health Catalyst pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RHE or HCAT?
Regional Health Properties quarterly revenues are $4.2M, which are smaller than Health Catalyst quarterly revenues of $76.4M. Regional Health Properties's net income of -$982K is higher than Health Catalyst's net income of -$14.7M. Notably, Regional Health Properties's price-to-earnings ratio is 0.13x while Health Catalyst's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Regional Health Properties is 0.16x versus 1.39x for Health Catalyst. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RHERegional Health Properties0.16x 0.13x $4.2M -$982K HCATHealth Catalyst1.39x -- $76.4M -$14.7M
-
Which has Higher Returns RHE or OPCH?
Option Care Health has a net margin of -23.24% compared to Regional Health Properties's net margin of 4.21%. Regional Health Properties's return on equity of -489.72% beat Option Care Health's return on equity of 14.65%.
Company Gross Margin Earnings Per Share Invested Capital RHERegional Health Properties44.9% -$0.52 $43.9M OPCHOption Care Health20.08% $0.31 $2.5B -
What do Analysts Say About RHE or OPCH?
Regional Health Properties has a consensus price target of --, signalling upside risk potential of 330.46%. On the other hand Option Care Health has an analysts' consensus of -- which suggests that it could grow by 31.43%. Given that Regional Health Properties has higher upside potential than Option Care Health, analysts believe Regional Health Properties is more attractive than Option Care Health.
Company Buy Ratings Hold Ratings Sell Ratings RHERegional Health Properties0 0 0 OPCHOption Care Health5 0 0 -
Is RHE or OPCH More Risky?
Regional Health Properties has a beta of 0.916, which suggesting that the stock is 8.446% less volatile than S&P 500. In comparison Option Care Health has a beta of 1.332, suggesting its more volatile than the S&P 500 by 33.16%.
-
Which is a Better Dividend Stock RHE or OPCH?
Regional Health Properties has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Option Care Health offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Regional Health Properties pays -- of its earnings as a dividend. Option Care Health pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RHE or OPCH?
Regional Health Properties quarterly revenues are $4.2M, which are smaller than Option Care Health quarterly revenues of $1.3B. Regional Health Properties's net income of -$982K is lower than Option Care Health's net income of $53.9M. Notably, Regional Health Properties's price-to-earnings ratio is 0.13x while Option Care Health's PE ratio is 19.25x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Regional Health Properties is 0.16x versus 0.84x for Option Care Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RHERegional Health Properties0.16x 0.13x $4.2M -$982K OPCHOption Care Health0.84x 19.25x $1.3B $53.9M
-
Which has Higher Returns RHE or OPRX?
OptimizeRx has a net margin of -23.24% compared to Regional Health Properties's net margin of -42.82%. Regional Health Properties's return on equity of -489.72% beat OptimizeRx's return on equity of -20.12%.
Company Gross Margin Earnings Per Share Invested Capital RHERegional Health Properties44.9% -$0.52 $43.9M OPRXOptimizeRx63.11% -$0.50 $149.7M -
What do Analysts Say About RHE or OPRX?
Regional Health Properties has a consensus price target of --, signalling upside risk potential of 330.46%. On the other hand OptimizeRx has an analysts' consensus of $10.36 which suggests that it could grow by 111.8%. Given that Regional Health Properties has higher upside potential than OptimizeRx, analysts believe Regional Health Properties is more attractive than OptimizeRx.
Company Buy Ratings Hold Ratings Sell Ratings RHERegional Health Properties0 0 0 OPRXOptimizeRx4 1 0 -
Is RHE or OPRX More Risky?
Regional Health Properties has a beta of 0.916, which suggesting that the stock is 8.446% less volatile than S&P 500. In comparison OptimizeRx has a beta of 1.341, suggesting its more volatile than the S&P 500 by 34.097%.
-
Which is a Better Dividend Stock RHE or OPRX?
Regional Health Properties has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. OptimizeRx offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Regional Health Properties pays -- of its earnings as a dividend. OptimizeRx pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios RHE or OPRX?
Regional Health Properties quarterly revenues are $4.2M, which are smaller than OptimizeRx quarterly revenues of $21.3M. Regional Health Properties's net income of -$982K is higher than OptimizeRx's net income of -$9.1M. Notably, Regional Health Properties's price-to-earnings ratio is 0.13x while OptimizeRx's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Regional Health Properties is 0.16x versus 1.01x for OptimizeRx. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income RHERegional Health Properties0.16x 0.13x $4.2M -$982K OPRXOptimizeRx1.01x -- $21.3M -$9.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is down 2.13% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 2.88% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 6.16% over the past day.
